Welcome to Targeting Microbiota 2018

What are the recent advances in fecal microbiota therapy?As new President of the International Society of Microbiota, I'm pleased to inform you about the organization of the two ISM meetings for 2018:
-

1st Symposium on Food & Microbiota
June 14, 2018 - Paris, France
Agenda available here.

-

6th World Congress on Targeting Microbiota
October 28-30, 2018 - Porto, Portugal
Preliminary agenda available here.

Intestinal microbiota and primary sclerosing cholangitis: Presentation of the recent scientific advances

Johhanes HovDr. Johannes Espolin Roksund Hov, from Oslo University Hospital, Norway will present his study related to "Intestinal microbiota and primary sclerosing cholangitis" during the 5th Targeting Microbiota World Congress 2017.

According to him: "Primary sclerosing cholangitis (PSC) is a chronic presumably autoimmune inflammatory disease of the biliary tree, often leading to endstage liver disease or incurable cancer of the bile ducts. No effetive medical treatment is available. Up to 80% of the patients have concomitant inflammatory bowel disease, making PSC the ultimate model of disturbances in the gut-liver axis. Does the key to the development - and also the treatment of the disease - lie in the gut? I will review the latest evidence of a role of the gut microbiota in PSC and discuss possible pathogenetic concepts​, which may also be relevant in autoimmune and inflammatory diseases in general."

For more information about Targeting Microbiota Congress, which will be held in Berlin on October 26-27, 2017: www.microbiota-site.com